The incidence of chest radiograph (CXR) abnormality appears to be lower in a cohort of swab-positive coronavirus disease (COVID-19) patients, including those identified from contact tracing, than previously reported, a Singapore study has found. Ground-glass opacity or consolidation was the predominant pattern, but mixed central and peripheral involvement is more common than peripheral involvement alone.
Initiating antiretroviral therapy (ART) seems to undo age acceleration epigenetic markers in patients with HIV-1, according to a recent study. The effects, however, are partial and are unable to completely reverse the age-associated methylation patterns associated with the infection.
Initiating COVID-19 patients with type 2 diabetes on sitagliptin at the time of hospitalization appears to reduce mortality and improve clinical outcomes as compared with administering standard-of-care treatment alone, a study has found.
Treatment with famotidine in hospitalized patients with the novel coronavirus disease (COVID-19) may help reduce the risk of death, results of a study have shown. It is also associated with a lower risk of the combined outcome of mortality and intubation, as well as decreased levels of serum markers for those with severe disease.
Aspirin appears to exert protective effects in patients with the novel coronavirus disease (COVID-19) by reducing the risk of death and the need for intensive care or mechanical ventilation, according to a recent study.
Quadrivalent human papillomavirus (HPV) vaccination can substantially reduce the risk of invasive cervical cancer, by up to almost 90 percent in women who were vaccinated early, a large Swedish registry-based study has shown.
The widespread adoption of self-testing for HIV (HIVST) may further weaken the testing for other sexually transmitted infections (STIs) among men who have sex with men (MSM), according to a recent Singapore study.
More than 9 months into the combat against COVID-19, the world has seen battles being stepped up on all fronts in the search for an effective therapy. While new drugs are being developed, old drugs are repurposed as potential treatment for COVID-19, and a plethora others are upcoming in the pipeline.